King® Guide Online Edition
Desktop, Tablet or Phone

We Begin 2021 With...

584 Monographs
5 New Drugs
169 New Peer Reviewed References
New Compatibility Information for 90 Drugs
New Stability Information for 52 Drugs

A complete list of our updates is available on our news & updates page.

We invite you to compare "What's In Your Database?"

Comparing IV Drug Databases

There are numerous vendors providing IV drug information, but there are only three major database sources for IV compatibility and stability data in the US (King Guide, Trissel2, and ASHP’s Handbook on Injectable Drugs). The Trissel2 database is licensed to many vendors offering IV drug modules like Lexicomp, Elsevier, Micromedex and others. As a result these vendors provide no real difference in the information offered in their IV drug information modules. ASHP recommends multiple sources of IV drug information be available to hospital pharmacy, so when considering adding to your library it is important to know the source of the data in order to truly add additional value and information.

Drug Shortages Demand Additional Information

The ongoing shortage of drugs, and especially small volume parenteral solutions, is causing changes in methods of drug administration. The King Guide® to Parenteral Admixtures® is designed to help practitioners decide which alternative administration strategy is best.

Switching to IV push, using solutions other than saline, using large volume solutions, or using syringe infusion pumps, may change the stability and compatibility characteristics of the medication to be administered. Fortunately, King® Guide, the oldest continuously published reference on parenteral drug stability and compatibility, is designed to provide practitioners with the timely information they need in this era of drug shortages.

In Hospital Pharmacy

The online edition started as a direct replacement for the original loose-leaf King Guide. Today hospital pharmacists have access to the entire King Guide in the pharmacy, at nurses stations, on-rounds, on-call at home, on tablets and phones - all with the same user interface and no software to install or maintain.

Authoritative Information

The King® Guide to Parenteral Admixtures® exceeds TJC requirements for updated references, is NABP endorsed and listed by name by many state pharmacy boards as a required reference.

Easy to Use

From a single drug to multiple drugs is shown in a clear easy to read format. Search fields self-populate with brand and generic drug names as you type, and compatibility results are instantly generated as you build your drug list.

No Software to Install or Maintain

With no software to install and no updates to apply practitioners are assured of having the latest and most up-to-date information available.  For added convenience, subscribers can login with an ip address and bypass the login screen.

Flexible Licensing

The King Guide is available everywhere, so we designed our subscriptions to be flexible. All subscriptions provide for access from any computer, tablet or phone. The single user license allows access from any computer or device from any location and limits access to one person at a time while the site license allows access from an unlimited number of computers or devices. A separate license is required for each facility location and we offer discounts for multiple licenses.

Features

  • Updated Quarterly Since 1971
  • Exceeds TJC Requirements
  • NABP Endorsed
  • Over 580 IV drugs with at-a-glance view of compatibility in 12 fluids
  • Over 3,100 Primary Source References
  • Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Y-Site, Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data.
  • Special Sections on Stability and Storage
  • Boxed Warning and Hazardous Drugs List and Identification
  • Proprietary and Generic Drug Names Included

Winter 2020

In this Supplement we added new monographs for CIFIDEROCOL SULFATE TOSYLATE, ISATUXIMAB, and SMOFLIPID.

We also added new stability information to these existing drug monographs: ACYCLOVIR SODIUM, AMIODARONE HYDROCHLORIDE, AMOXACILLIN SODIUM, AMPICILLIN SODIUM, AZTREONAM, BORTEZOMIB, BUSULFAN, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE SODIUM, CIPROFLOXACIN, CISATRACURIUM BESYLATE, CYTARABINE, GENTAMICIN SULFATE, HEPARIN SODIUM, HYDROCORTISONE SODIUM SUCCINATE, KETAMINE HYDROCHLORIDE, LEVOFLOXACIN, MEROPENEM, MORPHINE SULFATE, TOBRAMYCIN SULFATE, and VANCOMYCIN HYDROCHLORIDE.

New compatibility information was added to these existing drug monographs: ACETAMINOPHEN, ALBUMIN, HUMAN SERUM, BUSULFAN, CEFEPIME HYDROCHLORIDE, CEFTOLOZANE AND TAZOBACTAM, CIPROFLOXACIN, CISATRACURIUM BESYLATE, DORIPENEM, EPINEPHRINE HYDROCHLORIDE, ESOMEPRAZOLE SODIUM, FLUDARABINE PHOSPHATE, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, LEVOFLOXACIN, LEVOTHYROXINE SODIUM, MEROPENEM, and NOREPINEPHRINE BITARTRATE.


Ready to Order?


Buy Now  Purchase Order 

Have Questions?

View answers to our most frequently asked question

Documentation Contact Us